These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20105458)

  • 1. Stabilization of bacteriophage during freeze drying.
    Puapermpoonsiri U; Ford SJ; van der Walle CF
    Int J Pharm; 2010 Apr; 389(1-2):168-75. PubMed ID: 20105458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins III: collapse during storage at elevated temperatures.
    Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
    Eur J Pharm Biopharm; 2013 Oct; 85(2):240-52. PubMed ID: 23727369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manufacturing and ambient stability of shelf freeze dried bacteriophage powder formulations.
    Zhang Y; Peng X; Zhang H; Watts AB; Ghosh D
    Int J Pharm; 2018 May; 542(1-2):1-7. PubMed ID: 29486286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy.
    Kasraian K; Spitznagel TM; Juneau JA; Yim K
    Pharm Dev Technol; 1998 May; 3(2):233-9. PubMed ID: 9653761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation.
    Chang BS; Beauvais RM; Dong A; Carpenter JF
    Arch Biochem Biophys; 1996 Jul; 331(2):249-58. PubMed ID: 8660705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of PEG crystallization in frozen and freeze-dried PEGylated recombinant human growth hormone-sucrose systems: implications on storage stability.
    Bhatnagar BS; Martin SWH; Hodge TS; Das TK; Joseph L; Teagarden DL; Shalaev EY; Suryanarayanan R
    J Pharm Sci; 2011 Aug; 100(8):3062-3075. PubMed ID: 21491456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excipients for Room Temperature Stable Freeze-Dried Monoclonal Antibody Formulations.
    Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
    J Pharm Sci; 2020 Jan; 109(1):807-817. PubMed ID: 31622600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
    Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes.
    van den Hoven JM; Metselaar JM; Storm G; Beijnen JH; Nuijen B
    Int J Pharm; 2012 Nov; 438(1-2):209-16. PubMed ID: 22960501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation.
    Alfadhel M; Puapermpoonsiri U; Ford SJ; McInnes FJ; van der Walle CF
    Int J Pharm; 2011 Sep; 416(1):280-7. PubMed ID: 21771648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles.
    Zillies JC; Zwiorek K; Hoffmann F; Vollmar A; Anchordoquy TJ; Winter G; Coester C
    Eur J Pharm Biopharm; 2008 Oct; 70(2):514-21. PubMed ID: 18582569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humidity induced collapse in freeze dried cakes: A direct visualization study using DVS.
    Duralliu A; Matejtschuk P; Williams DR
    Eur J Pharm Biopharm; 2018 Jun; 127():29-36. PubMed ID: 29408372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved formulation and lyophilization cycle for rBCG vaccine.
    Jin TH; Nguyen L; Qu T; Tsao E
    Vaccine; 2011 Jun; 29(29-30):4848-52. PubMed ID: 21549782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trehalose and hyaluronic acid coordinately stabilized freeze-dried pancreatic kininogenase.
    Zhang Y; Ji B; Ling P; Zhang T
    Eur J Pharm Biopharm; 2007 Jan; 65(1):18-25. PubMed ID: 16950608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins I: stability after freeze-drying.
    Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
    J Pharm Sci; 2010 May; 99(5):2256-78. PubMed ID: 20039389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres.
    Puapermpoonsiri U; Spencer J; van der Walle CF
    Eur J Pharm Biopharm; 2009 May; 72(1):26-33. PubMed ID: 19118627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.